PE majors eye Orbicular Pharma stake, valuation seen up to $1.5 bn
Mumbai, Sept. 15 -- Orbicular Pharmaceutical Technologies has attracted early interest from private equity firms including Warburg Pincus and CVC Capital Partners, as the specialty pharmaceutical firm explores a stake sale in a deal that will likely value the company at up to $1.5 billion, three pe…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.